SMSLIFE
Invest Now
Start SIP in
SMSLIFE
Performance
- Low
- ₹1,296
- High
- ₹1,384
- 52 Week Low
- ₹626
- 52 Week High
- ₹1,750
- Open Price₹1,341
- Previous Close₹1,325
- Volume1,821
Investment Returns
- Over 1 Month + 21.55%
- Over 3 Month + 4.54%
- Over 6 Month -4.64%
- Over 1 Year + 88.52%
Smart Investing Starts Here Start SIP with SMS Lifesciences India for Steady Growth!
SMS Lifesciences India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 17.2
- PEG Ratio
- 0
- Market Cap Cr
- 396
- P/B Ratio
- 2.1
- Average True Range
- 114.02
- EPS
- 76.21
- Dividend Yield
- 0.1
- MACD Signal
- 75.97
- RSI
- 51.27
- MFI
- 82.36
SMS Lifesciences India Financials
SMS Lifesciences India Technicals
EMA & SMA
Current Price
₹1,310.30
-14.9
(-1.12%)

-
- Bearish Moving Average 6
-
- Bullish Moving Average 10
- 20 Day
- ₹1,322.28
- 50 Day
- ₹1,245.41
- 100 Day
- ₹1,222.59
- 200 Day
- ₹1,159.12
Resistance and Support
1330.1
- R3 1,451.90
- R2 1,417.90
- R1 1,364.10
- S1 1,276.30
- S2 1,242.30
- S3 1,188.50
SMS Lifesciences India Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-12 | Quarterly Results & Others | To consider other business matters. per share(15%)Dividend |
2024-11-13 | Quarterly Results | |
2024-08-09 | Quarterly Results & A.G.M. | |
2024-05-27 | Audited Results & Dividend | |
2024-02-10 | Quarterly Results & Others |
SMS Lifesciences India F&O
About SMS Lifesciences India
- NSE Symbol
- SMSLIFE
- BSE Symbol
- 540679
- Managing Director
- Mr. TVVSN Murthy
- ISIN
- INE320X01016
Similar Stocks to SMS Lifesciences India
SMS Lifesciences India FAQs
SMS Lifesciences India share price is ₹1,310 As on 02 May, 2025 | 06:25
The Market Cap of SMS Lifesciences India is ₹396.1 Cr As on 02 May, 2025 | 06:25
The P/E ratio of SMS Lifesciences India is 17.2 As on 02 May, 2025 | 06:25
The PB ratio of SMS Lifesciences India is 2.1 As on 02 May, 2025 | 06:25
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.